RODNEY MARKIN
Corporate Board Profile
Tech Score:
0
/100
← Back to All Directors
Cardiff Oncology, Inc.
Filing Date
Source Excerpt
2015-10-16
Rodney Markin As of December 31, 2014, 36,230 stock options were outstanding, of which none were exercisable.
Data sourced from SEC filings. Last updated: 2026-02-03